OXIS PRE 14C TO EFFECT REVERSE SPLIT AND INCREASE AUTHORIZED SHARES

Company

GT Biopharma, Inc.

Filed

March 24, 2017

Period of Report

March 24, 2017

Accession Number

0000939798-17-000033